On 26 February 2019, orphan designation (EU/3/19/2134) was granted by the European Commission to FGK Representative Service GmbH, Germany for 9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester (also known as RT001) for the treatment of infantile neuroaxonal dystrophy.
9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester
|Disease / condition||
Treatment of infantile neuroaxonal dystrophy
|Date of decision||
|Orphan decision number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.